INS and metabolic dysfunction-associated steatohepatitis: Accordingly, we have previously shown that NASH-related epigenetic alterations associate with changes in insulin action, [30] Contrary to what was expected based on previous studies, [58, 59], we did not find any significant change in the proportions of the only-SFA associated CpGs and cholesterol and/or LDL-c levels.